Skip to content
Research Article Open access CC BY 4.0

High Risk Human Papilloma Virus Genotyping and Cervical Cytology as Screening Tests for Cervical Cancer in Human Immunodeficiency Virus Positive Women in Nigeria

K. Tamunomie Nyengidiki, P. Boma Athanasius

Journal of Cancer and Tumor International · pp. 1–7 · Published 1 Apr 2016

10.9734/JCTI/2016/25209

Abstract

Introduction: The integration of high risk oncogenic strains of human papillomavirus into the genome of cells in the cervix results in specific cytopathic changes. The propensity for dysplastic changes is worst in the presence of depressed immunity. Aim: To compare screening methods by the identification of oncogenic strains of human papillomavirus (hrHPV) in cervical smears and the cytopathic changes among human immunodeficiency virus (HIV) positive patients. Study Design: Prospective cross-sectional study Place and duration: Antiretroviral clinic and Cancer screening centre of the University of Port Harcourt Teaching Hospital, between 24th October- 30th of December, 2014. Methodology: Eighty -two HIV positive women from the antiretroviral clinic with an equal number of HIV negative women were recruited as control. The presence of hrHPV genotypes were identified using real time polymerase chain reaction technique. Cytological examination of cervical smears was done. The information obtained was processed using the SPSS version 20 software. Results are presented in tables, test validity computed, test of significance and association done using student’s t-test and Odds ratio with P value < 0.05. Results: HrHPV strains were more common among HIV infected women (P=0.03 OR 3.34 CI 1.03-10.84). High grade intraepithelial neoplasia was significantly associated with hrHPV (P=0.006, OR 14.75 CI 2.32-93.91). HrHPV genotyping as a screening test was 88% specific with negative predictive value of 96.7% (CI 0.89-1.0) for determining high grade intraepithelial lesions Conclusion: Human immunodeficiency virus infected women are associated with higher risk of acquiring highly oncogenic strains of HPV. High risk HPV genotyping with high specificity and negative predictive values in identification of patients with dysplastic changes should be used as adjunct to cytological screening in HIV positive patients.  

High risk HPV genotyping cervical smears Nigeria

References (20)

  1. 1 TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMES [DOI]
  2. 2 The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women [DOI]
  3. 3 Epidemiology of cervical cancer with special focus on India [DOI]
  4. 4 Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study [DOI]
  5. 5 Human Papillomavirus Infection and Cervical Cytology in Women Screened for Cervical Cancer in the United States, 2003–2005 [DOI]
  6. 6 Cervical Cancer Screening of Women Living with HIV Infection: A Must in the Era of Antiretroviral Therapy [DOI]
  7. 7 HIV and cancer of the cervix [DOI]
  8. 8 The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa [DOI]
  9. 9 George Papanicolaou (1883–1962): Discoverer of the Pap smear [DOI]
  10. 10 Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women [DOI]
  11. 11 Cancer of the cervix and cervical screening: Current knowledge, attitude and practices of female health workers in Sokoto, Nigeria [DOI]
  12. 12 Épidémiologie de l’infection à HPV [DOI]
  13. 13 Prevalence of Human Papilloma Virus DNA in HIV Positive Women in Lagos University Teaching Hospital (LUTH) Lagos, Nigeria [DOI]
  14. 14 Profile and retrospective analysis of the use of preventive strategies in patients with cervical cancer in South-South Nigeria [DOI]
  15. 15 Cancer mortality among patients admitted to gynecological wards at Lagos University Teaching Hospital, Nigeria [DOI]
  16. 16 Screening for gynaecological cancers [DOI]
  17. 17 Human papillomavirus (HPV) infection and abnormal cervical cytopathology among human immuno- deficiency virus (HIV) positive women in Northern India [DOI]
  18. 18 Premalignant Lesions of the Female Genital Tract
  19. 19 Cervical neoplasia in the patient with HIV infection [DOI]
  20. 20 Adding Human Papillomavirus Testing to Cytology for Primary Cervical Cancer Screening: Shooting First and Asking Questions Later [DOI]

Cited by 3

Pattern of Cervical Cytology and High Risk Human Papillomavirus Strains in Non HIV Positive Women Presenting for Cervical Cancer Screening in Port Harcourt, Nigeria

T. K. Nyengidiki, E. O. Oranu · Journal of Biosciences and Medicines · 2018

Showing 1 of 3 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

40

Page views

0

PDF downloads

18

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.